Recent Coverage

February 16, 2021 Defining Best Practices for Interhospital Transfers

Interhospital transfers (IHT) are important yet recognized as high-risk transitions in care. This study was funded by CRICO to help define the best practice principles for IHTs and identify improvement opportunities.


February 12, 2021 The MPL Association Appoints Mark Reynolds, CRICO President and CEO, a Board Officer

CRICO President and CEO Mark E. Reynolds has been named as a board member of the Medical Practice Liability Association.

November 16, 2020 Development and Validation of a Deep Learning Model for Detection of Allergic Reactions Using Safety Event Reports Across Hospitals

This study, funded by CRICO grants, utilized a deep learning algorithm to identify instances of allergic reactions in the free-text electronic narratives of hospital safety reports.


View All News & Research

A Quality Improvement Approach to Rheumatoid Arthritis Management With Biologic Disease-Modifying Antirheumatic Drugs: Assessing Variability in a Treatment Pathway

  • January 1, 2017

A quality improvement project to improve rheumatoid arthritis management in clinical practice was supported by CRICO funds. The aim of the research was to understand the variability in prescribing practices of rheumatologists and reducing this variability if and when appropriate.

This initiative,  conducted at the Arthritis Center at Brigham and Women’s Hospital, had three distinct but related steps:


  1. Development of an internally endorsed treatment pathway.
  2. Detailed retrospective Chart reviews.
  3. Improved documentation of functional status and disease activity measures.


Citation for the Full-text Article

Dave AJ, Tory HO, Awosogba JA, Coblyn JS, Bermas B, Solomon DH, Desai SP. A quality improvement approach to rheumatoid Arthritis management with biologic disease-modifying antirheumatic drugs: assessing variability in a treatment pathwayJ Clin Rheumatol. 2017 Jan;23(1):66-69. doi: 10.1097/RHU.0000000000000474.